Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-15 Sale |
2025-04-17 4:05 pm |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
15,329 | $5.95 | $91,208 | 343,073 (Indirect Direct) |
View |
2025-01-30 Purchase |
2025-02-03 5:38 pm |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,714,285 | $8.75 | $49,999,994 | 19,889,683 (Indirect) |
View |
2025-01-21 Purchase |
2025-01-23 7:38 pm |
89bio Inc. | ETNB | McWherter Charles Director |
15,000 | $6.6567 | $99,850 | 25,000 (Direct) |
View |
2025-01-15 Sale |
2025-01-17 4:01 pm |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
10,963 | $6.49 | $71,150 | 271,833 (Direct) |
View |
2024-12-06 Purchase |
2024-12-10 06:02 am |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
5,000 | $7.89 | $39,450 | 471,236 (Direct) |
View |
2024-12-05 Purchase |
2024-12-09 06:01 am |
89bio Inc. | ETNB | McWherter Charles Director |
10,000 | $8 | $80,000 | 10,000 (Direct) |
View |
2024-11-22 Purchase |
2024-11-25 06:05 am |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
10,000 | $8.35 | $83,500 | 466,236 (Direct) |
View |
2024-10-30 Sale |
2024-11-01 4:01 pm |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
27,955 | $8.12 | $226,995 | 187,796 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-04-02 Option Award |
2025-02-19 4:01 pm |
N/A 2034-04-02 |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
49,900 | $0 | 402,302 (Indirect) |
View |
2025-02-17 Tax Withholding |
2025-02-19 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
1,050 | $10.57 | 402,302 (Direct) |
View |
2025-02-01 Option Award |
2025-02-19 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
8,750 | $9.6 | 402,302 (Indirect) |
View |
2025-02-17 Tax Withholding |
2025-02-19 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
3,249 | $10.57 | 862,240 (Direct) |
View |
2025-02-17 Tax Withholding |
2025-02-19 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
780 | $10.57 | 269,674 (Direct) |
View |
2025-02-17 Tax Withholding |
2025-02-19 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
1,050 | $10.57 | 318,834 (Direct) |
View |
2025-02-09 Tax Withholding |
2025-02-11 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
8,946 | $11.41 | 864,692 (Direct) |
View |
2025-02-09 Tax Withholding |
2025-02-11 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
3,828 | $11.41 | 270,454 (Direct) |
View |
2025-02-09 Tax Withholding |
2025-02-11 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
3,793 | $11.41 | 344,702 (Direct) |
View |
2025-02-09 Tax Withholding |
2025-02-11 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
3,817 | $11.41 | 319,884 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 6:02 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
56,400 | $0 | 56,400 (Indirect) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | DiRocco Derek Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | Zoth Lota S. Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | Babler Martin Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | Altschuler Steven Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | LAPORTE KATHLEEN Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | Hayden Michael R Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | Atkinson Edward Morrow III Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | McWherter Charles Director |
56,400 | $0 | 56,400 (Direct) |
View |
2025-02-01 Option Award |
2025-02-04 9:35 pm |
N/A 2035-02-01 |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
380,000 | $0 | 574,282 (Direct) |
View |
2025-02-01 Tax Withholding |
2025-02-04 9:35 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
3,338 | $9.6 | 574,282 (Direct) |
View |
2025-02-01 Option Award |
2025-02-04 9:34 pm |
N/A 2035-02-01 |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
400,000 | $0 | 668,495 (Direct) |
View |
2025-02-01 Tax Withholding |
2025-02-04 9:34 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
3,338 | $9.6 | 668,495 (Direct) |
View |
2025-02-01 Option Award |
2025-02-04 9:32 pm |
N/A 2035-02-01 |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
1,260,000 | $0 | 1,721,638 (Direct) |
View |
2025-02-01 Tax Withholding |
2025-02-04 9:32 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
9,598 | $9.6 | 1,721,638 (Direct) |
View |
2025-02-01 Option Award |
2025-02-04 9:32 pm |
N/A 2035-02-01 |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
400,000 | $0 | 643,701 (Direct) |
View |
2025-02-01 Tax Withholding |
2025-02-04 9:32 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
3,338 | $9.6 | 643,701 (Direct) |
View |
2025-02-01 Option Award |
2025-02-04 9:29 pm |
N/A 2035-02-01 |
89bio Inc. | ETNB | Sarena Francis Willard Chief Operating Officer |
268,750 | $0 | 293,750 (Direct) |
View |
2024-12-12 Option Award |
2024-12-16 06:11 am |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
95,000 | $0 | 247,039 (Direct) |
View |
2024-12-12 Option Award |
2024-12-16 06:10 am |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
95,000 | $0 | 282,796 (Direct) |
View |
2024-12-12 Option Award |
2024-12-16 06:10 am |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
95,000 | $0 | 197,620 (Direct) |
View |
2024-09-09 Tax Withholding |
2024-09-10 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
5,352 | $8.46 | 152,039 (Direct) |
View |
2024-09-09 Tax Withholding |
2024-09-10 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
3,212 | $8.46 | 102,620 (Direct) |
View |
2024-09-09 Tax Withholding |
2024-09-10 4:01 pm |
N/A N/A |
89bio Inc. | ETNB | Le-Nguyen Quoc See Remarks |
5,352 | $8.46 | 215,751 (Direct) |
View |
2024-08-17 Tax Withholding |
2024-08-19 5:34 pm |
N/A N/A |
89bio Inc. | ETNB | Mansbach Harry H Chief Medical Officer |
1,046 | $8.04 | 157,391 (Direct) |
View |
2024-08-17 Tax Withholding |
2024-08-19 5:29 pm |
N/A N/A |
89bio Inc. | ETNB | PALEKAR ROHAN Chief Executive Officer |
4,601 | $8.04 | 456,236 (Direct) |
View |
2024-08-17 Tax Withholding |
2024-08-19 5:28 pm |
N/A N/A |
89bio Inc. | ETNB | Martins Ryan Chief Financial Officer |
777 | $8.04 | 105,832 (Direct) |
View |